Clinical Trials

A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad 50 mcg and 100 mcg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients with Head and Neck Cancer (PSHCI 13-017) (IRB# 43366)

Status: Active

 

 

A Randomized Phase II Trial of ARQ 197 (tivantinib)/Cetuximab versus Cetuximab in Patients with Recurrent/Metastatic Head and Neck Cancer (NCI 9165) (IRB# PSHCI-13-031)

Status: Active

 

 

Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck (RTOG 1216) (IRB# PSHCI-13-058)

Status: Active